Jane Ellen Giamporcaro
Overview
Explore the profile of Jane Ellen Giamporcaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
669
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarkisian Jr S, Grover D, Gallardo M, Brubaker J, Giamporcaro J, Hornbeak D, et al.
J Glaucoma
. 2022 Oct;
32(1):9-18.
PMID: 36260288
Prcis: The iStent Infinite Trabecular Micro-Bypass System implanted in patients with open angle glaucoma (OAG) (uncontrolled by prior surgical or medical therapy) was effective in reducing mean diurnal intraocular pressure...
2.
Samuelson T, Sarkisian Jr S, Lubeck D, Stiles M, Duh Y, Romo E, et al.
Ophthalmology
. 2019 Mar;
126(6):811-821.
PMID: 30880108
Purpose: Evaluate the safety and effectiveness of an ab interno implanted (iStent inject) Trabecular Micro-Bypass System (Glaukos Corporation, San Clemente, CA) in combination with cataract surgery in subjects with mild...
3.
Neuhann T, Hornbeak D, Neuhann R, Giamporcaro J
J Cataract Refract Surg
. 2019 Mar;
45(3):312-320.
PMID: 30851807
Purpose: To assess 5-year outcomes after implantation of 1 trabecular microbypass stent during cataract surgery in eyes with open-angle glaucoma (OAG) or ocular hypertension. Setting: Private ophthalmology clinic (AaM Augenklinik...
4.
Myers J, Masood I, Hornbeak D, Belda J, Auffarth G, Junemann A, et al.
Adv Ther
. 2018 Feb;
35(3):395-407.
PMID: 29476443
Introduction: This study evaluates long-term outcomes of two trabecular micro-bypass stents, one suprachoroidal stent, and postoperative prostaglandin in eyes with refractory open angle glaucoma (OAG). Methods: Prospective ongoing 5-year study...
5.
Katz L, Erb C, Carceller Guillamet A, Fea A, Voskanyan L, Giamporcaro J, et al.
Clin Ophthalmol
. 2018 Feb;
12:255-262.
PMID: 29440867
Purpose: Evaluate long-term outcomes after one, two, or three trabecular micro-bypass stents implanted in a standalone procedure in eyes with open-angle glaucoma taking ocular hypotensive medication. Patients And Methods: Prospective...
6.
Berdahl J, Voskanyan L, Myers J, Hornbeak D, Giamporcaro J, Katz L, et al.
Clin Exp Ophthalmol
. 2017 Apr;
45(8):797-802.
PMID: 28384377
Importance: Additional data are sought regarding treatment options for glaucoma, a major cause of global blindness. Background: The study assessed outcomes following standalone implantation of two second-generation trabecular micro-bypass stents...
7.
Chang D, Donnenfeld E, Katz L, Voskanyan L, Ahmed I, Samuelson T, et al.
Clin Ophthalmol
. 2017 Mar;
11:523-528.
PMID: 28352151
Purpose: To evaluate the long-term intraocular pressure (IOP)-lowering effect and safety parameters following treatment with two trabecular micro-bypass stents and topical prostaglandin in phakic eyes with open-angle glaucoma (OAG) not...
8.
Gallardo M, Supnet R, Giamporcaro J, Hornbeak D
Clin Ophthalmol
. 2016 Oct;
10:1931-1937.
PMID: 27784981
Purpose: The purpose of this study was to evaluate intraocular pressure (IOP) and topical ocular hypotensive medication burden at 12 months postoperatively in a predominantly Hispanic patient population with primary...
9.
Lindstrom R, Lewis R, Hornbeak D, Voskanyan L, Giamporcaro J, Hovanesian J, et al.
Adv Ther
. 2016 Oct;
33(11):2082-2090.
PMID: 27739003
Introduction: The study objective was to evaluate the intraocular pressure (IOP) and medication-lowering effect of 2 second-generation trabecular micro-bypass stents in eyes with open-angle glaucoma (OAG) on one preoperative medication....
10.
Katz L, Erb C, Carceller G, Fea A, Voskanyan L, Wells J, et al.
Clin Ophthalmol
. 2015 Dec;
9:2313-20.
PMID: 26715834
Purpose: To assess the safety and efficacy of one, two, or three trabecular microbypass stents in eyes with primary open-angle glaucoma (OAG) not controlled on ocular hypotensive medication. A total...